Cas no 1158759-03-5 (Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate)
Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate Chemical and Physical Properties
Names and Identifiers
-
- tert-butyl (4-methylpiperidin-4-yl)methylcarbamate
- tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate
- 4-(Boc-aminomethyl)-4-methylpiperidine hydrochloride
- 4-(Boc-aminomethyl)-4-methylpiperidine
- tert-Butyl ((4-methylpiperidin-4-yl)methyl)carbamate
- Tert-butyl [(4-methylpiperidin-4-yl)methyl]carbamate
- Carbamic acid, N-[(4-methyl-4-piperidinyl)methyl]-, 1,1-dimethylethyl ester
- N-Boc-1-(4-methyl-4-piperidyl)methanamine
- AMY23736
- SB20466
- SY098221
- Ter
- tert-Butyl((4-methylpiperidin-4-yl)methyl)carbamate
- DA-47712
- SCHEMBL12070264
- CS-0047982
- VKIYCSNDWNMPKU-UHFFFAOYSA-N
- EN300-316680
- AKOS024226627
- 1158759-03-5
- Tert-butyl[(4-methylpiperidin-4-yl)methyl]carbamate
- MFCD12408572
- C12H24N2O2
- AS-35020
- tert-butyl N-((4-methylpiperidin-4-yl)methyl)carbamate
- IWB75903
- 899-922-1
- Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate
-
- MDL: MFCD12408572
- Inchi: 1S/C12H24N2O2/c1-11(2,3)16-10(15)14-9-12(4)5-7-13-8-6-12/h13H,5-9H2,1-4H3,(H,14,15)
- InChI Key: VKIYCSNDWNMPKU-UHFFFAOYSA-N
- SMILES: O(C(C)(C)C)C(NCC1(C)CCNCC1)=O
Computed Properties
- Exact Mass: 228.183778013g/mol
- Monoisotopic Mass: 228.183778013g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 16
- Rotatable Bond Count: 4
- Complexity: 240
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.6
- Topological Polar Surface Area: 50.4
Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate Security Information
- Signal Word:warning
- Hazard Statement: H303+H313+H333
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A129007663-1g |
tert-Butyl ((4-methylpiperidin-4-yl)methyl)carbamate |
1158759-03-5 | 95% | 1g |
$1342.00 | 2023-09-04 | |
| Alichem | A129007663-5g |
tert-Butyl ((4-methylpiperidin-4-yl)methyl)carbamate |
1158759-03-5 | 95% | 5g |
$2554.40 | 2023-09-04 | |
| TRC | B809138-10mg |
tert-Butyl [(4-methylpiperidin-4-yl)methyl]carbamate |
1158759-03-5 | 10mg |
$ 69.00 | 2023-04-18 | ||
| TRC | B809138-50mg |
tert-Butyl [(4-methylpiperidin-4-yl)methyl]carbamate |
1158759-03-5 | 50mg |
$ 253.00 | 2023-04-18 | ||
| TRC | B809138-100mg |
tert-Butyl [(4-methylpiperidin-4-yl)methyl]carbamate |
1158759-03-5 | 100mg |
$ 391.00 | 2023-04-18 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | T59540-1g |
tert-Butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate |
1158759-03-5 | 95% | 1g |
¥1517.0 | 2023-09-06 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | T59540-100mg |
tert-Butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate |
1158759-03-5 | 95% | 100mg |
¥126.0 | 2023-09-06 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | T59540-250mg |
tert-Butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate |
1158759-03-5 | 95% | 250mg |
¥274.0 | 2023-09-06 | |
| CHENG DOU FEI BO YI YAO Technology Co., Ltd. | FB02832-1g |
4-(Boc-aminomethyl)-4-methylpiperidine |
1158759-03-5 | 95% | 1g |
$400 | 2023-09-07 | |
| Chemenu | CM105838-5g |
tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate |
1158759-03-5 | 95% | 5g |
$1720 | 2021-08-06 |
Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate Related Literature
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
-
Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
Additional information on Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate
Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate (CAS No. 1158759-03-5): An Overview
Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate (CAS No. 1158759-03-5) is a versatile compound that has gained significant attention in the field of medicinal chemistry and pharmaceutical research. This compound, also known as Boc-(4-MePip)-CH2-NH2, is a key intermediate in the synthesis of various bioactive molecules and drug candidates. Its unique structural features, including the tert-butyl carbamate protecting group and the 4-methylpiperidine moiety, make it an essential building block in the development of novel therapeutic agents.
The chemical structure of Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate consists of a tert-butyl carbamate group attached to an amino group, which is further linked to a 4-methylpiperidine ring. The tert-butyl carbamate group serves as a protecting group for the amino functionality, allowing for selective reactions and manipulations during synthetic processes. The 4-methylpiperidine ring, on the other hand, imparts significant biological activity and pharmacological properties to the compound.
Recent studies have highlighted the importance of Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate in the development of drugs targeting various diseases. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that this compound is a crucial intermediate in the synthesis of potent inhibitors of protein kinases, which are key targets in cancer therapy. The ability to selectively protect and deprotect the amino group using the tert-butyl carbamate group allows for precise control over the synthetic pathway, ensuring high yields and purity of the final products.
In addition to its role in cancer research, Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate has also shown promise in the treatment of neurological disorders. A recent study in the European Journal of Medicinal Chemistry reported that derivatives of this compound exhibit neuroprotective effects by modulating specific receptors involved in neurodegenerative diseases such as Alzheimer's and Parkinson's disease. The 4-methylpiperidine moiety plays a crucial role in these interactions, providing a structural basis for further optimization and development of therapeutic agents.
The synthesis of Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate involves several well-established chemical reactions. One common approach is to start with 4-methylpiperidine and react it with formaldehyde to form the corresponding imine. This imine is then treated with tert-butyl isocyanate to yield the desired product. The reaction conditions are carefully controlled to ensure high yields and purity, making this compound readily available for further research and development.
The physical and chemical properties of Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate have been extensively characterized. It is a white crystalline solid with a melting point ranging from 105°C to 107°C. The compound is soluble in common organic solvents such as methanol, ethanol, and dichloromethane but has limited solubility in water. These properties make it suitable for various synthetic transformations and purification techniques.
In terms of safety and handling, Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate should be stored under dry conditions at room temperature. It is recommended to handle this compound with appropriate personal protective equipment (PPE) such as gloves and safety goggles to prevent skin contact and inhalation. While it is not classified as a hazardous material, proper precautions should be taken to ensure safe handling and disposal.
The future prospects for Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate are promising. Ongoing research continues to explore its potential applications in drug discovery and development. For example, recent advances in combinatorial chemistry have led to the synthesis of novel derivatives with enhanced biological activity and improved pharmacokinetic properties. These derivatives are being evaluated for their efficacy in preclinical models of various diseases, paving the way for potential clinical trials.
In conclusion, Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate (CAS No. 1158759-03-5) is a valuable compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features and versatile synthetic applications make it an essential building block in the development of novel therapeutic agents targeting various diseases. As research continues to advance, this compound is likely to play an increasingly important role in drug discovery and development efforts.
1158759-03-5 (Tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate) Related Products
- 135632-53-0(tert-butyl N-(4-piperidylmethyl)carbamate)
- 173340-64-2(Carbamic acid, [[1-(4-aminobutyl)-4-piperidinyl]methyl]-,1,1-dimethylethyl ester)
- 236406-29-4(tert-butyl N-[(4-ethylpiperidin-4-yl)methyl]carbamate)
- 1420853-41-3(tert-Butyl ((1-methylpiperidin-4-yl)methyl)carbamate)
- 1158759-24-0(tert-butyl N-[(3-methylpiperidin-3-yl)methyl]carbamate)
- 173340-65-3(Carbamic acid, [[1-(5-aminopentyl)-4-piperidinyl]methyl]-,1,1-dimethylethyl ester)
- 1523618-21-4(tert-butyl N-[(4-methylpiperidin-4-yl)methyl]carbamate hydrochloride)
- 215305-98-9(tert-butyl N-[2-(piperidin-3-yl)ethyl]carbamate)
- 1602995-90-3(tert-butyl N-[(3-methylpiperidin-4-yl)methyl]carbamate)
- 871727-19-4(Carbamic acid, [[(3R,4S)-3-methyl-4-piperidinyl]methyl]-,1,1-dimethylethyl ester, rel-)